Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting β2-agonists: results of the pacman cohort

Influence of β2-adrenergic receptor polymorphisms on asthma exacerbation in children with severe asthma regularly receiving salmeterol

(2013) Verónica Giubergia et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Genetics of onset of asthma

(2013) F. Nicole Dijk et al.   Current Opinion in Allergy and Clinical Immunology

Tailored second-line therapy in asthmatic children with the Arg16genotype

(2012) Brian J. Lipworth et al.   CLINICAL SCIENCE

Predictors of Symptoms Are Different From Predictors of Severe Exacerbations From Asthma in Children

(2011) Ann Chen Wu et al.   CHEST

Pharmacogenetics of asthma

(2010) Rodolfo M Pascual et al.   CURRENT OPINION IN PHARMACOLOGY

β2-Receptor Polymorphisms in Patients Receiving Salmeterol with or without Fluticasone Propionate

(2009) Eugene R. Bleecker et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Adrenergic β2-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol

(2009) Kaninika Basu et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Effect of β2-adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial

(2009) Michael E Wechsler et al.   LANCET

Pharmacogenetics of anti-inflammatory treatment in children with asthma: rationale and design of the PACMAN cohort

(2009) Ellen S Koster et al.   PHARMACOGENOMICS